Y. Okada et al., Development of plasmin-selective inhibitors and studies of their structure-activity relationship, CHEM PHARM, 48(2), 2000, pp. 184-193
Various compounds were synthesized by combining three components at positio
ns P1, P-1' and P-2'. Of these, N-(trans-4-aminomethylcyclohexanecarbonyl)-
Tyr(O-2-bromobenzyloxycarbonyl)-octylamide inhibited plasmin selectively wi
th IC50 values of 0.80 and 0.23 mu M towards S-2251 and fibrin, respectivel
y This compound also inhibited plasma kallikrein, urokinase, thrombin and t
rypsin with IC50 values of 10, >50, >50 and 1.6 mu M, respectively.